Analysis of the role of RAS Family Mutations in Metastatic Colorectal Cancer (mCRC): Current Treatment Practice
A major challenge in metastatic colorectal cancer (mCRC) is the identification of specific biomarkers that are likely to predict which patients will benefit from a specific treatment. To this date, a number of studies have shown that a tumour's mutational profile influences treatment outcome in pati...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Sciendo
2014-12-01
|
| Serie: | Forum of Clinical Oncology |
| Soggetti: | |
| Accesso online: | https://doi.org/10.2478/fco-2014-0008 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|